ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 904

Ultrasound Synovitis Reflects Synovial Inflammation at a Histopathological Level

Nora Ng, Stephen Kelly, Frances Humby, Maria DiCicco, Vidalba Rocher, Rebecca Hands, Michele Bombardieri and Costantino Pitzalis, Centre for Experimental Medicine and Rheumatology, William Harvey Research Institute, Queen Mary University of London, London, United Kingdom

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: Early Rheumatoid Arthritis, Rheumatoid arthritis (RA), synovitis and ultrasound

  • Tweet
  • Email
  • Print
Session Information

Title: Imaging of Rheumatic Diseases: Ultrasound

Session Type: Abstract Submissions (ACR)

Background/Purpose:

Ultrasound (US) is widely used by rheumatologists to assess inflammatory burden on patients with inflammatory arthritis. Some studies have shown that US measures of inflammation reflects aspects of histological synovitis in a heterogeneous groups of patients with rheumatoid arthritis (RA). Little work has been done to describe this relationship in an early arthritis population.

Our aim of this study is to investigate, at a single joint level, the correlation of US synovitis with histological synovial inflammation before and after treatment initiation in a homogenous cohort of patients with early RA.

Methods:

Data was collected from 54 patients with early RA (fulfills 1987 ACR classification, symptom onset <12 months). Patients were naïve to both disease modifying anti-rheumatic drugs (DMARD) and to steroids. All patients underwent a core data set assessment including clinical, biochemical, imaging and an US guided minimally invasive synovial biopsy of the most inflamed joint. Patients were then initiated on DMARD according to standardised protocol. A repeat assessment and US guided biopsy was performed at 6 months follow up. US images of the joint are scored using a semi quantitative score (0-3). Sections of paraffin embedded synovial tissue received immunohistochemical staining for CD3, CD20, CD68, CD68sland CD138 and these parameters were graded in a semiquantitative fashion (0-4). Spearman's rho was used to correlate scores at each time point.

Results:

At baseline, US power doppler (PD) was significantly correlated with histological markers of inflammation – CD3 (r=0.43, p<0.05), CD20 (r=0.46, p<0.01), CD68 (r=0.37, p<0.05), CD68sl (r=0.46, p<0.01) and CD138 (r=0.61, p<0.001), and with inflammatory markers erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) (r=0.4, p <0.05).  After 6 months of therapy, most of these correlations were still present, most notably with CD68sl (p<0.05). Interestingly, we also found that a fall in US PD in response to treatment at 6 months is associated with a fall in CD68sl (r=0.50, p<0.005) and a fall in DAS28 (r= 0.40, p<0.05).

Conclusion:

US PD has long been recognised as an accurate reflection of disease activity in inflammatory arthritis. Our results have shown that US PD also reflects synovial inflammation at a histopathological level. The association of US PD, CD68sl and DAS28 supports the current opinion that Power Doppler US is a biomarker for treatment response and reflects both clinical and histological markers of disease activity in patients with RA.


Disclosure:

N. Ng,
None;

S. Kelly,
None;

F. Humby,
None;

M. DiCicco,
None;

V. Rocher,
None;

R. Hands,
None;

M. Bombardieri,
None;

C. Pitzalis,
None.

  • Tweet
  • Email
  • Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/ultrasound-synovitis-reflects-synovial-inflammation-at-a-histopathological-level/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology